HIVE Digital Technologies Past Earnings Performance
Past criteria checks 0/6
HIVE Digital Technologies's earnings have been declining at an average annual rate of -12.4%, while the Software industry saw earnings growing at 9.8% annually. Revenues have been growing at an average rate of 29.3% per year.
Key information
-12.4%
Earnings growth rate
-4.4%
EPS growth rate
| Software Industry Growth | 8.2% |
| Revenue growth rate | 29.3% |
| Return on equity | -22.8% |
| Net Margin | -42.8% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Slammed 25% HIVE Digital Technologies Ltd. (CVE:HIVE) Screens Well Here But There Might Be A Catch
Mar 23
Market Cool On HIVE Digital Technologies Ltd.'s (CVE:HIVE) Revenues Pushing Shares 28% Lower
Feb 03HIVE Digital Technologies Ltd.'s (CVE:HIVE) 25% Jump Shows Its Popularity With Investors
Dec 20Is HIVE Digital Technologies (CVE:HIVE) Using Too Much Debt?
Oct 11Is HIVE Blockchain Technologies (CVE:HIVE) A Risky Investment?
Jun 21HIVE Blockchain Technologies (CVE:HIVE) Is Making Moderate Use Of Debt
Mar 10Under The Bonnet, HIVE Blockchain Technologies' (CVE:HIVE) Returns Look Impressive
Jul 19Is Now The Time To Put HIVE Blockchain Technologies (CVE:HIVE) On Your Watchlist?
Jun 12HIVE Blockchain Technologies Ltd.'s (CVE:HIVE) 30% Dip In Price Shows Sentiment Is Matching Earnings
Apr 28HIVE Blockchain Technologies (CVE:HIVE) Could Become A Multi-Bagger
Mar 30Do HIVE Blockchain Technologies's (CVE:HIVE) Earnings Warrant Your Attention?
Mar 09Here's Why HIVE Blockchain Technologies (CVE:HIVE) Can Manage Its Debt Responsibly
Feb 16Investors Should Be Encouraged By HIVE Blockchain Technologies' (CVE:HIVE) Returns On Capital
Nov 03HIVE Blockchain Technologies (CVE:HIVE) Has A Pretty Healthy Balance Sheet
Sep 28Here's Why We Don't Think HIVE Blockchain Technologies's (CVE:HIVE) Statutory Earnings Reflect Its Underlying Earnings Potential
Jan 20
Revenue & Expenses BreakdownBeta
How HIVE Digital Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 96 | -41 | 23 | 0 |
| 30 Sep 23 | 79 | -128 | 24 | 0 |
| 30 Jun 23 | 86 | -137 | 22 | 0 |
| 31 Mar 23 | 106 | -236 | 22 | 0 |
| 31 Dec 22 | 138 | -277 | 21 | 0 |
| 30 Sep 22 | 192 | -132 | 20 | 0 |
| 30 Jun 22 | 216 | -60 | 18 | 0 |
| 31 Mar 22 | 211 | 80 | 18 | 0 |
| 31 Dec 21 | 196 | 109 | 16 | 0 |
| 30 Sep 21 | 141 | 76 | 12 | 0 |
| 30 Jun 21 | 100 | 46 | 10 | 0 |
| 31 Mar 21 | 68 | 24 | 7 | 0 |
| 31 Dec 20 | 39 | 29 | 4 | 0 |
| 30 Sep 20 | 30 | 15 | 4 | 0 |
| 30 Jun 20 | 27 | -5 | 5 | 0 |
| 31 Mar 20 | 29 | -2 | 5 | 0 |
| 31 Dec 19 | 30 | -73 | 6 | 0 |
| 30 Sep 19 | 34 | -113 | 6 | 0 |
| 30 Jun 19 | 30 | -130 | 6 | 0 |
| 31 Mar 19 | 32 | -138 | 6 | 0 |
| 31 Dec 18 | 35 | -74 | 7 | 0 |
| 30 Sep 18 | 30 | -37 | 8 | 0 |
| 30 Jun 18 | 24 | -28 | 11 | 0 |
| 31 Mar 18 | 13 | -26 | 9 | 0 |
| 31 Dec 17 | 3 | -20 | 7 | 0 |
| 30 Sep 17 | 0 | -20 | 4 | 0 |
| 30 Jun 17 | 0 | 0 | 0 | 0 |
| 31 Mar 17 | 0 | -1 | 0 | 0 |
| 31 Dec 16 | 0 | -1 | 0 | 0 |
| 30 Sep 16 | 0 | -1 | 0 | 0 |
| 30 Jun 16 | 0 | -1 | 0 | 0 |
| 31 Mar 16 | 0 | -1 | 0 | 0 |
| 31 Dec 15 | 0 | -1 | 0 | 0 |
| 30 Sep 15 | 0 | -1 | 0 | 0 |
| 30 Jun 15 | 0 | -1 | 0 | 0 |
| 31 Mar 15 | 0 | -1 | 0 | 0 |
| 31 Dec 14 | 0 | -1 | 0 | 0 |
| 30 Sep 14 | 0 | -1 | 0 | 0 |
| 30 Jun 14 | 0 | -1 | 0 | 0 |
| 31 Mar 14 | 0 | -1 | 0 | 0 |
| 31 Dec 13 | 0 | -1 | 0 | 0 |
| 30 Sep 13 | 0 | 0 | 0 | 0 |
Quality Earnings: HIVE is currently unprofitable.
Growing Profit Margin: HIVE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: HIVE is unprofitable, and losses have increased over the past 5 years at a rate of 12.4% per year.
Accelerating Growth: Unable to compare HIVE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: HIVE is unprofitable, making it difficult to compare its past year earnings growth to the Software industry (10.4%).
Return on Equity
High ROE: HIVE has a negative Return on Equity (-22.79%), as it is currently unprofitable.